According to a new report by Polaris Market Research, the global mycoplasma testing market was valued at USD 1.2 billion in 2024 and is projected to reach USD 4.3 billion by 2034, expanding at a CAGR of 13.50% over the forecast period. Growth is underpinned by heightened biopharmaceutical production, stringent contamination-control standards, and rising research activity focused on...